comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 00:38:19 - browse：529

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Will Ozempic

entertainment

knowledge

WSS

Will Ozempic

Hospital price transparency does save money, advocate argues

Four alarming medical procedures we’re glad history forgot

Will Ozempic

UnitedHealth’s board chair also owns a personal investment firm

FDA struggles to regulate food additives, sometimes for decades

Wikipedia

comprehensive

hotspot

Hollywood unions extend contract negotiations for actors

Eli Lilly expects to double planned employment in Boston center

The high cost of giving birth even with insurance

CEOs share strategies for surviving biotech slump

In age of alternative facts, a scholarly course on calling out crap

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Guidelines to prevent youth baseball injuries need more muscle

Drug companies' payments and gifts affect physicians' prescribing

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH confirmation hearing shows politicization of research

knowledge

Scientists uncover potential path to treating deadly childhood tumor

People with mental disorders often marry others with same

Senate committee scrutinizes Medicare Advantage brokers

First Opinion on colorectal cancer screening: letter and response

Pancreatic cancer is often deadly, but new discoveries are raising hope

UnitedHealth, in a surprise, takes aim at Steward’s physician group

focus

entertainment

knowledge

hotspot